DIA Europe 2026

UBC is excited to join the biopharma community at DIA Europe 2026, a flagship forum for advancing regulatory science, real-world evidence, and patient safety across the product lifecycle. DIA Europe convenes leaders from industry, academia, and health authorities to share practical approaches for evidence generation, risk mitigation, and compliance—driving better outcomes for patients and sponsors.

UBC’s integrated model combines evidence development, pharmacovigilance, and safety & risk management to help sponsors make informed decisions, meet regulatory expectations, and maintain transparent, patient centric programs. From real-world data strategies to end-to-end safety operations and REMS, our team supports clinical and post market needs with scalable, compliant solutions.

• Evidence Development Solutions: Registries, observational studies, and RWE strategies that generate actionable insights for regulatory and market access decision making.
• Pharmacovigilance: Global case processing, signal detection, aggregate reporting, and safety surveillance across the product lifecycle./li>
• Safety & Risk Management: REMS design and implementation, risk minimization measures, and ongoing program management aligned with regulatory guidance.
• Integrated Approach: Cohesive, patient focused services that link evidence generation with safety operations for end-to-end support.
• Proven Partnership: Experience across diverse therapeutic areas and complex programs, backed by quality systems and operational excellence.

Connect with UBC at DIA Europe 2026 to discuss how our EDS, PV, and SRM solutions can support your clinical and post market priorities.